Next |
home / stock / inmb / inmb message board
Subject | By | Source | When |
---|---|---|---|
Did the trial in ovarian ever start? | jondoeuk | investorshub | 04/11/2023 7:45:58 PM |
Don't need to convince us. We are fully | derkampfer | investorshub | 04/09/2023 1:10:54 PM |
Sure, it is early days in patients, but | jondoeuk | investorshub | 04/06/2023 11:10:04 PM |
blocked | dennisdave | investorshub | 12/01/2022 3:05:20 PM |
INMB chart....finally a reversal? | conix | investorshub | 03/30/2022 1:11:42 AM |
$INMB Chart | conix | investorshub | 09/21/2021 5:21:04 PM |
XPro news also impressive. Data very. The data | derkampfer | investorshub | 09/02/2021 12:10:24 PM |
INKmune news was impressive. Albeit one patient dosed | derkampfer | investorshub | 08/26/2021 3:45:08 PM |
Almost, $13 to $10 is a downward slope. | spartex | investorshub | 05/09/2021 12:03:21 AM |
Booooooom? More like, BurP! LOL. Still | spartex | investorshub | 05/08/2021 11:59:16 PM |
New run began today. Deeper dive Alzheimers drug | derkampfer | investorshub | 04/17/2021 2:27:32 AM |
$INMB just ran from $2.00 to 30.00 congrats | Fress | investorshub | 01/21/2021 12:56:46 PM |
I need a bigger rake to scoop up | john sezso | investorshub | 01/06/2021 9:58:37 PM |
Still crickets here.... | john sezso | investorshub | 01/06/2021 1:59:36 AM |
Good enough for Harry Reid it's good enough | john sezso | investorshub | 12/31/2020 2:46:09 PM |
They are speaking with Roth Capital right now | byrdiesoccer | investorshub | 10/28/2020 1:13:41 PM |
Shorts bring this to 8 I wanna buy | akamaii | investorshub | 10/17/2020 2:35:47 PM |
$INMB CHART >>>> going in position before test | l2 hunter | investorshub | 07/21/2020 3:48:27 PM |
Wow that public offering is peanuts ...Kaboom here tomorrow | starkd748 | investorshub | 07/20/2020 10:25:45 PM |
znewcar1: INMB 26% v1,8M c14.08 f10,9M H14.74 looking strong aft hours | znewcar1 | investorshangout | 07/20/2020 10:21:52 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-22 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Boca Raton, Florida, April 22, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced today t...
Novel Immunotherapy Approach Targets Soluble Tumor Necrosis Factor to Overcome Resistance and Enhance Therapeutic Outcome in High-Risk Breast Cancer Boca Raton, Florida, April 08, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage im...